• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫学原理和跨学科科学能否为攻克艾滋病疫苗及应对其他全球健康挑战指明方向?

Can immunological principles and cross-disciplinary science illuminate the path to vaccines for HIV and other global health challenges?

作者信息

Wilson Christopher B, Karp Christopher L

机构信息

Global Health Program, Bill & Melinda Gates Foundation, 500 Fifth Avenue North, Seattle, WA 98109, USA

Global Health Program, Bill & Melinda Gates Foundation, 500 Fifth Avenue North, Seattle, WA 98109, USA.

出版信息

Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671). doi: 10.1098/rstb.2014.0152.

DOI:10.1098/rstb.2014.0152
PMID:25964461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4527394/
Abstract

Vaccines are one of the most impactful and cost-effective public health measures of the twentieth century. However, there remain great unmet needs to develop vaccines for globally burdensome infectious diseases and to allow more timely responses to emerging infectious disease threats. Recent advances in the understanding of immunological principles operative not just in model systems but in humans in concert with the development and application of powerful new tools for profiling human immune responses, in our understanding of pathogen variation and evolution, and in the elucidation of the structural aspects of antibody-pathogen interactions, have illuminated pathways by which these unmet needs might be addressed. Using these advances as foundation, we herein present a conceptual framework by which the discovery, development and iterative improvement of effective vaccines for HIV, malaria and other globally important infectious diseases might be accelerated.

摘要

疫苗是20世纪最具影响力且成本效益最高的公共卫生措施之一。然而,在开发针对全球负担沉重的传染病的疫苗以及更及时地应对新出现的传染病威胁方面,仍存在巨大的未满足需求。不仅在模型系统中,而且在人类中,对免疫原理理解的最新进展,与用于分析人类免疫反应的强大新工具的开发和应用、我们对病原体变异和进化的理解以及对抗体 - 病原体相互作用结构方面的阐明相结合,揭示了满足这些未满足需求的途径。以这些进展为基础,我们在此提出一个概念框架,通过该框架可以加速针对艾滋病毒、疟疾和其他全球重要传染病的有效疫苗的发现、开发和迭代改进。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f3/4527394/0761024e6a2b/rstb20140152-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f3/4527394/f0a9eeb5ac3b/rstb20140152-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f3/4527394/0761024e6a2b/rstb20140152-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f3/4527394/f0a9eeb5ac3b/rstb20140152-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f3/4527394/0761024e6a2b/rstb20140152-g2.jpg

相似文献

1
Can immunological principles and cross-disciplinary science illuminate the path to vaccines for HIV and other global health challenges?免疫学原理和跨学科科学能否为攻克艾滋病疫苗及应对其他全球健康挑战指明方向?
Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671). doi: 10.1098/rstb.2014.0152.
2
Challenges in the development of an HIV-1 vaccine.人类免疫缺陷病毒1型疫苗研发中的挑战。
Nature. 2008 Oct 2;455(7213):613-9. doi: 10.1038/nature07352.
3
The global HIV vaccine enterprise.全球艾滋病疫苗企业。
Int Microbiol. 2005 Jun;8(2):93-101.
4
Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS.针对艾滋病的创新型预防和治疗疫苗的开发方法。
Adv Exp Med Biol. 2009;655:189-242. doi: 10.1007/978-1-4419-1132-2_14.
5
HIV vaccine: Can it be developed in the 21st century?HIV疫苗:21世纪能研发出来吗?
Hum Vaccin Immunother. 2016;12(1):222-4. doi: 10.1080/21645515.2015.1064571.
6
State of the science. HIV vaccine development.科学现状。HIV疫苗研发。
Nurs Clin North Am. 1996 Mar;31(1):25-39.
7
DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.DNA疫苗分子佐剂SP-D-BAFF和SP-D-APRIL增强抗gp120免疫反应并提高HIV-1中和抗体滴度。
J Virol. 2015 Apr;89(8):4158-69. doi: 10.1128/JVI.02904-14. Epub 2015 Jan 28.
8
Complex immune correlates of protection in HIV-1 vaccine efficacy trials.HIV-1疫苗疗效试验中复杂的保护性免疫相关因素。
Immunol Rev. 2017 Jan;275(1):245-261. doi: 10.1111/imr.12514.
9
Prospects for a globally effective HIV-1 vaccine.全球有效的HIV-1疫苗的前景。
Vaccine. 2015 Nov 27;33 Suppl 4:D4-12. doi: 10.1016/j.vaccine.2015.03.059. Epub 2015 Jun 20.
10
HIV vaccine development: past, present and future.HIV疫苗的研发:过去、现在与未来。
IDrugs. 2010 Dec;13(12):852-6.

引用本文的文献

1
A reply to DeVico, Lewis & Gallo (2015).对德维科、刘易斯和加洛(2015年)的回复。
Philos Trans R Soc Lond B Biol Sci. 2015 Nov 5;370(1681). doi: 10.1098/rstb.2015.0347.
2
Modulating the durability of anti-HIV gp120 antibody responses after vaccination: a comment on Wilson & Karp (2015).疫苗接种后调节抗HIV gp120抗体反应的持久性:对Wilson和Karp(2015年)的评论
Philos Trans R Soc Lond B Biol Sci. 2015 Nov 5;370(1681). doi: 10.1098/rstb.2015.0199.
3
Biological challenges to effective vaccines in the developing world.发展中世界有效疫苗面临的生物学挑战。

本文引用的文献

1
Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies.在亲和力成熟过程中操控选择力以产生交叉反应性HIV抗体。
Cell. 2015 Feb 12;160(4):785-797. doi: 10.1016/j.cell.2015.01.027. Epub 2015 Feb 5.
2
HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.HIV 抗体。抗原修饰调节广谱和窄谱中和 HIV 抗体的竞争。
Science. 2014 Dec 12;346(6215):1380-1383. doi: 10.1126/science.1259206.
3
The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.
Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671). doi: 10.1098/rstb.2014.0138.
一种预防B群脑膜炎奈瑟菌病的新型疫苗的发现与研发。
Hum Vaccin Immunother. 2015;11(1):5-13. doi: 10.4161/hv.34293. Epub 2014 Nov 1.
4
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants.通过靶向病毒逃逸变体的常见抗体增强HIV-1免疫疗法。
J Exp Med. 2014 Nov 17;211(12):2361-72. doi: 10.1084/jem.20141050. Epub 2014 Nov 10.
5
T follicular helper cell differentiation, function, and roles in disease.T滤泡辅助细胞的分化、功能及其在疾病中的作用。
Immunity. 2014 Oct 16;41(4):529-42. doi: 10.1016/j.immuni.2014.10.004.
6
Polyreactivity and autoreactivity among HIV-1 antibodies.HIV-1 抗体的多反应性和自身反应性。
J Virol. 2015 Jan;89(1):784-98. doi: 10.1128/JVI.02378-14. Epub 2014 Oct 29.
7
Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development.抗体持久性与T细胞平衡:HIV疫苗研发面临的两个关键因素。
Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15614-21. doi: 10.1073/pnas.1413550111. Epub 2014 Oct 27.
8
Structure and immune recognition of trimeric pre-fusion HIV-1 Env.三聚体融合前HIV-1包膜糖蛋白的结构与免疫识别
Nature. 2014 Oct 23;514(7523):455-61. doi: 10.1038/nature13808. Epub 2014 Oct 8.
9
TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination.Toll样受体5(TLR5)介导的肠道微生物群感知对于季节性流感疫苗接种的抗体反应是必要的。
Immunity. 2014 Sep 18;41(3):478-492. doi: 10.1016/j.immuni.2014.08.009. Epub 2014 Sep 11.
10
Dynamic signaling by T follicular helper cells during germinal center B cell selection.滤泡辅助性 T 细胞在生发中心 B 细胞选择过程中的动态信号传递。
Science. 2014 Aug 29;345(6200):1058-62. doi: 10.1126/science.1257861.